Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ossium Health, Inc.
City of Hope Medical Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Baptist Health South Florida
Arog Pharmaceuticals, Inc.
Columbia University
Washington University School of Medicine
Arog Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
Children's Oncology Group
Fred Hutchinson Cancer Center
St. Petersburg State Pavlov Medical University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center